Merck sets sights on PBAC

By Megan Brodie 3 years ago | In Products
  • 3 years ago

4 February 2021 Merck‚Äôs new lung cancer precision drug TEPMETKO (tepotinib) is expected to appear…

This is subscriber-only content. Please login to continue reading.